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AbstrACt
Objectives Cardiovascular disease (CVD) prevention 
guidelines recommend that patients’ future CVD risk (as 
a percentage) is estimated and used to inform shared 
treatment decisions. We sought to understand the 
perspectives of patients with hypertension on their future 
risk of CVD.
Design Qualitative, semistructured interviews and 
thematic analysis.
Participants People with hypertension who had not 
experienced a cardiovascular event recruited from primary 
care.
setting Participants were purposively sampled from two 
primary care practices in South London. Interviews were 
transcribed, and a thematic analysis was conducted.
results 24 people participated; participants were diverse 
in age, sex, ethnicity and socioeconomic status. Younger 
working-aged people were under-represented. Contrasting 
with probabilistic risk, many participants understood 
future CVD as binary and unknowable. Roughly half of 
participants avoided contemplating future CVD risk; for 
some, lifestyle change and medication obviated the need 
to think about CVD risk. Some participants identified with 
one portion of the probability fraction (‘I’d be one of those 
ones.’). Comparison with peers (typically partners, siblings 
and friends of a similar age, including both ‘healthy’ and 
‘unhealthy’ people) was most frequently used to describe 
risk, both among those who engaged with and avoided risk 
discussion. This contrasts with current risk scores, which 
describe probabilities in people with similar risk factors; 
many participants did not identify with such a group, and 
hence did not find these probabilities meaningful, even 
where correctly understood.
Conclusions Risk as typically calculated and 
communicated (eg, the risk of ‘100 people like you’) may 
not be meaningful for patients who do not identify with 
the denominator. Comparing an individual’s risk with their 
peers could be more meaningful.
IntrODuCtIOn 
Cardiovascular diseases (CVDs) comprise 
coronary artery disease, peripheral vascular 
and aortic disease and stroke and are the 
top cause of death globally.1 Deciding about 
whether to start treatment to prevent CVD 
involves weighing up finely balanced bene-
fits and harms.2–4 Current guidelines recom-
mend that clinicians produce an estimate of 
a person’s global risk (ie, levels of multiple 
risk factors are measured and combined to 
produce a risk estimate using an algorithm 
often embedded in the electronic patient 
record).5–7 This risk estimate is most often 
expressed as the percentage probability of 
developing CVD in the subsequent 10 years. 
There is a large body of evidence about how 
to communicate risks most effectively. Among 
others: strategies such as using natural 
frequencies with a common denominator, 
and icon grids (or ‘smiley face charts’) have 
been found to make risk easier to understand 
and are less liable to mislead.8
Fewer qualitative studies have examined the 
perspectives of healthy individuals on their 
future risk of CVD.i A systematic review by 
Garside and colleagues in 2008 identified nine 
qualitative studies that discussed perspectives 
on risk, but all focused on knowledge of risk 
factors rather than risk in the probabilistic 
sense.9 Davison and colleagues published a 
series of papers describing their qualitative 
study in South Wales that focused on the 
causation of CVD.10–12 The authors described 
difficulty in translating population-level data 
to individuals. Specifically, participants in this 
study had strong ideas of the type of person 
i Here we differentiate between risk (meaning a 
likelihood, probability, or uncertainty) and risk 
factor (meaning the factors, such as hypertension 
and smoking, which increase the risk of CVD).
strengths and limitations of this study
 ► This study used qualitative methods to better un-
derstand the perspectives of people with hyperten-
sion on their future risk of developing cardiovascular 
disease.
 ► The participants were diverse socioeconomically, 
and concerning ethnicity, country of origin, age, sex 
and length of time diagnosed with hypertension.
 ► We were unable to recruit any participants under the 
age of 50 years, which may limit the generalisability 
of the results.
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who was a ‘candidate’ for heart disease, typically a person 
with multiple and markedly high lifestyle risk factors (a 
fact the authors attribute to the successful penetration of 
health promotion campaign messages). Each encounter 
with an individual who does not meet this extreme risk 
picture (which as the authors note, accounts for most heart 
disease incidence) is regarded as an anomaly or random 
incident. Davison argues that health promotion messages 
focusing on single lifestyle risk factors might paradox-
ically reduce motivation to change lifestyle, if heart 
disease is seen as random and inevitable. More recently, 
Damman and Timmermans conducted a qualitative study 
of 40 Dutch lay people, examining their understanding 
of risk factors.13 They found that participants saw CVD 
risk as dichotomous (ie, they would either become sick 
or not) rather than on a continuum. Polak and Green, in 
their qualitative study of 34 people who had been offered 
statins, found that few participants considered risk infor-
mation relevant in their decision making and instead saw 
treatment as necessary to treat the risk factor (ie, their 
cholesterol level) rather than the risk (their estimated 
probability of CVD). Bonner and colleagues conducted a 
qualitative analysis of data from 25 Australian participants 
who were encouraged to ‘talk aloud’ when using two CVD 
risk communication tools.14 They concluded that partic-
ipants needed a reference point (example risk probabil-
ities being anchored to ‘high risk’ and ‘low risk labels) 
to make sense of the probabilities and additionally found 
that CVD risk estimates derived from a larger number risk 
factors were felt to be more credible.
This study sought, through in-depth interviews, to 
investigate patient perspectives on future CVD risk and 
understand how these might impact treatment decisions. 
Specifically, we sought to understand the ideas patients 
with hypertension have about their risk of CVD, the 
language and concepts patients use in their discussion of 
risk and how patients respond to example risk informa-
tion, presented in a similar format to currently available 
decision aids.
MethODs
Patient and public involvement
The study protocol and interview schedule were informed 
by helpful feedback from the members of the King’s 
College London Stroke Research Patients and Family 
Group.
sampling and data collection
We interviewed patients from two general practices 
(primary care practices) in South London. Participants 
were eligible if they had been diagnosed as having hyper-
tension but with no previous diagnosed CVD. Those with 
secondary hypertension (eg, pregnancy-related hyperten-
sion) or diabetes were also excluded, since their expe-
riences seemed likely to differ. Participants were invited 
to participate voluntarily, provided with study informa-
tion to read and asked to sign a written consent form if 
they agreed to take part. Participants were purposively 
sampled, aiming for maximum variation in age, ethnic 
group, a variety of times since diagnosis and approxi-
mately equal numbers of men and women.15 We initially 
planned to conduct the research at a single practice, 
but after some of the initial interviews were completed, 
we added a second practice located in an area with 
higher socioeconomic deprivation to increase the diver-
sity of participants. Since purposive strategies allow 
the researcher deliberate choice over recruitment, it is 
regarded as legitimate (and often good practice) to adapt 
recruitment strategies over the study. The first practice 
had approximately 20 000 registered patients; the second 
practice had around 12 000 registered patients. Both prac-
tices were located in South East London and cared for a 
highly mobile, multiethnic population; both had a large 
population with hypertension. Potential participants were 
identified from the practices’ hypertension registers, and 
a maximum diversity sample (based on age, sex, ethnicity, 
and duration of diagnosis) were invited via a letter from 
their own doctor. We later changed to face-to-face invita-
tion aiming to increase the diversity of participants. To 
ensure our study complied with the ethics committee 
requirements, initial contact had to be from the patient’s 
own doctor, and we do not have access to data on the 
characteristics of those who declined to participate/did 
not respond at this stage. The recruitment sites were 
chosen to ensure that the interviewer and participants 
would have no prior knowledge of one another.
We piloted and refined a semistructured interview 
schedule at a meeting of the King’s College London 
Stroke Research Patients and Family Group (see online 
appendix). All interviews were conducted by IJM, a 
general practitioner from a practice in a neighbouring 
borough, who was a PhD student at the time of the inter-
views and who had undergone training in conducting 
qualitative interviews. During the first two interviews, the 
concept of future risk was difficult to discuss; participants 
appeared to find it too abstract. To overcome this, we 
developed a hypothetical decision aid (see figure 1). This 
decision aid was similar in format to existing CVD decision 
aids, such as the Statin Choice decision aid,16 and followed 
guideline recommendations about optimal methods for 
communicating CVD risk.17 The decision aid was used to 
introduce and prompt discussion around risk, rather as 
an evaluation of this decision aid specifically. We showed 
this decision aid to participants as the last part of the 
interview to avoid influencing responses to earlier ques-
tions. Interviews were conducted until data saturation was 
reached. Qualitative data analysis typically overlaps with 
data collection; we transcribed and conducted an initial 
analysis of data in parallel with conducting the interviews, 
together with written notes made by the interviewer. 
Interview transcripts, notes from ongoing interviews and 
the emerging analysis were reviewed regularly at meetings 
of the investigators (IJM, CDAW and CM) where the deci-
sion about data saturation was made, defined as when no 
new themes appeared to be generated from interviews.18
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Analysis
Interviews were audio recorded and transcribed verbatim. 
We did not seek further feedback from participants on the 
transcripts, other than seeking clarification of any unclear 
points during the course of the interview. The transcripts 
were analysed using thematic analysis as described by 
Ziebland and McPherson.19 This is a form of grounded 
theory, where analytical categories are developed induc-
tively from the data, rather than defined beforehand. 
Specifically, the interview transcripts were coded line-by-
line using Dedoose, a qualitative research web applica-
tion.20 Codes were developed iteratively; new codes were 
added as needed to describe the interview data. Finally, 
these reports were used to produce a final analysis, in 
which connections and groupings between codes can be 
made, and overarching themes understood. Ziebland and 
McPherson describe this as the one sheet of paper (OSOP) 
method, in which the issues from report texts are identi-
fied in depth and written down on a single (often large) 
sheet of paper together with a participant identifier.19 
The researcher can place themes in closer proximity to 
others that appear to be related. By doing this iteratively, 
a map of the themes develops, and lines can be drawn in 
to represent the connections. The output of this stage is a 
map of concepts and their relationships, from which the 
supporting evidence (the relevant text snippets) may be 
retrieved. In practice, IJM coded the interview transcripts. 
CM separately coded a sample, and the coding scheme 
was discussed and revised in regular meetings of IJM, CM 
and CDAW over the course of the data collection. It was 
at these meetings that the decision about data saturation 
was taken. The OSOP method was done initially by IJM, 
then refined following discussion with CM and CDAW.
results
Characteristics of participants
Twenty-four interviews were conducted; a description 
of participants’ characteristics is given in table 1. Partic-
ipants had diverse occupations, including engineers, 
cleaners, health professionals, teachers and manual 
labourers. FIfteen of 24 participants had retired from 
employment. Participants were aged from 51 years to 
90 years, with 46% male. Fifty-four per cent were born in 
the UK, while the remainder were born in Africa (21%), 
the Caribbean (13%), France, Ireland and the USA (one 
participant each (4%)). Self-reported ethnicity was 54% 
white British, 13% white other, 21% black African and 
13% black Caribbean. Participants had received a hyper-
tension diagnosis between 2 months and 33 years prior 
to the interview. Twenty-two participants were prescribed 
regular medication with widely varying reported patterns 
of medication taking (ranging from participants who 
took medication regularly without fail to those who took 
it rarely, or when it was perceived as needed). One partic-
ipant had taken medication previously but decided to 
stop, and one participant was considering whether to start 
medication following a recent meeting with her doctor.
thematic analysis
We summarise our findings as a lay model of risk under-
standing, as shown in figure 2. Our key finding was that 
CVD risk probabilities were often understood from an 
individual perspective (rather than, as intended, popu-
lation probabilities). This led to understandings of risk 
presentation that widely differed from their intended 
meaning. Perspectives on risk were informed by partic-
ipants’ understanding of the causes of hypertension 
and CVD, and often through seeing CVD as a sudden, 
unpredictable and fatal event. Many participants 
avoided contemplating future CVD risk, as they found 
it unpleasant, pointless, that it was not a priority in the 
context of advancing age or other illness or preferred to 
focus on positive aspects of life. For those who did engage 
with risk discussion, risk information was interpreted in 
a number of unexpected ways. Many participants did not 
identify with the reference population. For some, risk esti-
mates would not take sufficient account of factors they 
felt to be important (including both factors ignored by 
the models and factors not accorded sufficient weight). 
Some participants felt that since no two individuals could 
ever be the same, population probabilities could never 
make sense. Others identified with either the affected 
Figure 1 Example risk chart provided to participants as the 
final part of the interviews.
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or unaffected portion of the fraction. Conversely, peer 
comparison was widely used by participants and appeared 
to be an acceptable and meaningful way of discussing 
risk. These themes are presented in detail below.
Causes and consequences of hypertension
Most of the participants explained their hypertension by 
way of conventional biomedical risk factors; the majority 
mentioned one or more of advancing age, obesity, a family 
history, poor diet and lack of exercise as contributing. These 
factors were widely described as causative of high blood pres-
sure but as causative of complications of high blood pressure.
Several participants who were born outside of the 
UK attributed their hypertension to their new envi-
ronment. Many participants identified that stress 
contributed to their hypertension. For some of these 
participants, stress was regarded as highly important, 
and for several, it was regarded as the primary cause of 
hypertension. For several participants, a stressful life 
Table 1 Characteristics of participants
Interviewee code Practice Age category Sex Ethnicity Time since diagnosis
A 2 70–80 M White British 5 years
B 2 60–70 F White US 3 months
C 1 50–60 M White British 19 years
D 1 60–70 F White British 12 years
E 2 60–70 M Black Caribbean 15 years
F 1 70–80 M White British 5 years
G 1 60–70 M White British 3 years
H 1 80+ M White British 33 years
I 2 60–70 M White British 3 years
J 1 80+ M White British 6 years
K 1 60–70 F White French 15 years
L 1 70–80 M Black African 30 years
M 2 50–60 F Black African 6 years
N 1 70–80 F White British 5 years
O 1 50–60 F Black Caribbean 2 months
P 1 70–80 F White British 10 years
Q 1 70–80 F White British 30 years
R 2 60–70 F Black Caribbean 15 years
S 2 70–80 F White British 7 years
T 2 70–80 M Black African 33 years
U 2 70–80 F White African 20 years
V 2 60–70 F Black African 2 years
W 2 80+ M White British 20 years
X 2 70–80 F White Irish 20 years
F, female; M, male.
Figure 2 A lay model of cardiovascular risk. CVD, cardiovascular disease.
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event was considered to be a trigger for hypertension 
starting.
A wide variety of consequences of having high blood 
pressure were described by participants; these could be 
broadly grouped as cardiovascular consequences and 
somatic consequences. Most of the participants described 
the possibility of developing an illness due to high blood 
pressure, particularly if not controlled, including stroke, 
heart attack and kidney disease. Several participants 
described complications as being sudden, unpredictable 
and severe; many reported sudden death as an important 
consequence of untreated hypertension. Several others 
described sudden increases in blood pressure as harmful, 
as illustrated by the following two quotes:
Well I mean I think it can be sort of damaging for the 
heart as, you know, if it really goes high. And I mean 
you could get a stroke, you know, a number of things 
really. (Interview Q)
At one point, it was extremely high, I borrowed my 
neighbours cuff, whatever you call it…sphyg… and 
er, the systolic was over 200 and I got a little fright-
ened… (Interview D)
Several participants described physical sensations they 
attributed to raises in blood pressure: these included head-
ache and breathlessness. One participant, who attributed 
physical symptoms to an acute increase in blood pressure, 
described how the absence of physical symptoms was an 
important marker of good control.
I am very careful about it, I have no problem with the 
blood pressure. If I feel that my head will explode. I 
relate it with the blood pressure, the only thing I do 
is I sit down and relax. I breathe deeply, and then 
with the relaxation it’s finished, it’s happened one in 
three months no more. (Interview K)
Attitudes towards future risk
A large portion of the interview comprised discussion 
about perceptions of risk. Participants were asked both 
if they had thought about this previously and also asked 
whether they considered themselves likely or unlikely 
to develop a complication of hypertension in future. 
However, around half of participants did not provide any 
sort of estimate of whether they would be at risk of hyper-
tension complications themselves, even after prompts.
Many participants expressed a desire to avoid contem-
plating future risk of disease, including both younger and 
older participants. Key reasons expressed by participants 
included: finding the consideration of future serious 
illness unpleasant or stressful; perceiving that looking at 
future risk did not make sense due to old age; and having 
other active health problems that were perceived as more 
serious making CVD risk less relevant (eg, pain from 
osteoarthritis).
The concept that contemplating future risk of heart 
disease or stroke was unpleasant is illustrated by the 
following quote from a 50-year-old man who worked as 
a senior teacher and otherwise saw himself as in good 
health:
I don’t know whether I would want to know if I’m at 
risk of stroke, because it would be quite upsetting if 
I’m at high risk. (Interview C)
Similarly, one participant (who was aged 90 years and 
continued to live a physically and socially active life and 
who went swimming daily) attributed his reluctance to 
consider future risk to a happy life.
I tell you, it’s an amazing life. I don’t worry about ill 
health. (Interview H)
During this part of the interviews, several partici-
pants expressed that a key benefit of maintaining good 
health was that they could avoid thinking about future 
risk. Another participant (a retired scientist, in his 80s) 
described the benefits of his healthy lifestyle:
I have always relied on good health and good living to 
obviate any need to question these things. (Interview 
J)
Another participant hinted that he felt saw himself 
as being at low risk, but also that being on medication 
meant he did not need to contemplate it further.
Will I get a stroke? No I don’t think I will. I haven’t 
considered it. Because I’m on the medication to stop 
it. (Interview C)
One participant (who retired early due to poor health) 
described having chronic pelvic pain and arthritis. For 
her, CVD was seen as a lower priority than her other 
health problems:
I mean I’ve had a couple of angiograms and my ar-
teries seem to be fine, so I haven’t really gone into it. 
As I say, to me, it’s the least of my medical problems, 
I haven’t really… I don’t feel like frightening myself 
with stuff. (Interview D)
Perspectives on risk probabilities
The example risk chart is shown in figure 1. All partici-
pants except one appeared to understand the risk chart’s 
intended meaning and from their discussions and ques-
tions appeared to understand the statistics presented. 
The exception was participant V who did not engage in 
discussion around the decision aid, saying only, ‘It’s good 
to take tablets’. Her response gave the impression she had 
found it difficult to understand both the text and statis-
tical contents of the tool.
Participants were mixed in their opinion about risk esti-
mates, with around half expressing a strong desire to have 
such information and around half stated that they would 
not find it useful.
Several participants expressed surprise at the content of 
the risk tool, explaining that they expected medication to 
have a bigger effect. This is illustrated by one participant 
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who expected that medication would abolish the risk of 
stroke altogether:
I was given the impression that it was ‘take that 
and you’ll be fine’ ‘take that and you won’t have a 
stroke…’ but not according to this [pointing at exam-
ple decision aid]… (Interview C)
One participant, surprised by what she saw as a small 
benefit of treatment, wondered if it would lead people to 
stop their treatment:
I mean I realise it’s double which is a lot but I thought 
it would be more like three or four times…So I tell 
you what it would do, is make me think oh it doesn’t 
seem to make all that much difference whether I take 
the tablet or not… If I had side-effects from it and I 
saw that, I’d think well maybe it isn’t worth it or may-
be it’s not worth it all the time, maybe I can skip it 
when I’m on vacation. (Interview B)
All participants were asked hypothetically whether 
the absolute benefits the example risk presentation (if 
they applied to them) would change their decision to 
take medication (since almost all took medication, this 
usually meant deciding to stop). None of the participants, 
including the two who were worried about others stop-
ping, answered that they would stop treatment themselves.
One participant explained that, for her, even a small 
absolute benefit of treatment would be worth taking:
Well yeah…cos if four people die here, and six people 
die here…you’d want to take the tablets. It’s about liv-
ing longer isn’t it. (Interview S)
risk factors from the individual perspective
Although the risk chart stated that the ‘at risk’ reference 
population was similar to the hypothetical patient in terms of 
known risk factors (age, sex, ethnic group, smoking history 
and cholesterol levels), many participants expressed a view 
that statistics such as the example could not represent their 
own risk. For these participants, risk factors outside of what 
is conventionally measured were highly important, and their 
absence led them to see the charts as unreliable and that 
they would not apply to them personally.
Several participants felt that even where a particular 
risk factor had been incorporated into the risk score, 
it had not been accorded enough importance. This is 
illustrated by a participant who moved to the UK from 
Nigeria, who perceived that his particularly healthy family 
history would be strongly protective.
It’s not in my lineage. We never suffered… just go. My 
senior brother just died 2 years ago. And he never had 
any illness until just once. My father was the same. My 
father lived to one-twenty years old, and I understand 
he never suffered any illness. But that time he just go. 
What I have in mind about will happen to me. I’ve 
made up my mind that that is what will happen to me. 
Of course. (Interview T)
One participant felt that the risk tool would not have 
taken into account his (relatively) healthy lifestyle:
Yeah, but if it could be more personalized. Because I 
don’t smoke, I hardly drink, I mean I do drink, I’m 
not a monk, but it kind of goes in phases. (Interview 
C)
Several participants went further, and since individuals 
are unique, questioned whether a group could ever be 
regarded as similar, as illustrated by one participant:
it does say ‘imagine a hundred people who are sim-
ilar to you’ but you see, who is? no person is similar 
to…you know… (Interview I)
seeking individual meaning from population statistics—‘I 
think I might be that one’
Several of the participants reported a pre-existing idea 
of their likelihood of developing CVD and reported 
that data from risk estimates was unlikely to change 
that view. This certainty is illustrated by one participant, 
a woman from Nigeria who saw herself in good health, 
who expressed disbelief after seeing the example chart, 
feeling already convinced of outcome of not using blood 
pressure treatment:
If like me, I don’t take treatment, someone will die, 
not like straight away, they die, it’s not having stroke, 
the person will just die. (Interview M)
However, several participants from a variety of back-
grounds seemed to identify with the affected part of the 
fraction. For example, the decision aid shown to the 
participant described that, if not taking amlodipine, 22 
out of 100 people would expect to die. These participants 
thought that they would likely be 1 of the 22 (rather than 
the intended meaning, of having an equal probability of 
being any one of the 100). This is illustrated by one partic-
ipant, using nearly identical wording to several others:
One person in a hundred is still one too many, and 
I’d be one of those. (Interview U)
For a few, this idea appeared to be precautionary. 
It seemed preferable to them to assume they would be 
affected by a complication in order that they could take 
any necessary action to prevent it. This is subtly different 
from perceiving they would certainly be affected. This 
is illustrated by a UK-born participant who wanted to 
prepare for the worst case:
Well, I think that I might be that one [laughs] or one 
of those, if I stopped taking it, that [I] would die from 
it or would have a stroke, so, you know, I would rather 
take the tablets than take that chance. … (Interview 
F)
However, this idea did not seem to be precautionary 
for all, and several participants appeared to perceive a 
certainty about developing or not developing illness. 
Several of the participants expressed the idea that certain 
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people are ‘stronger’, that is, more resistant to illness than 
others. A weak person would be susceptible to illness in 
general (not only CVD). A participant who moved to the 
UK from Nigeria described how ‘strong’ people would be 
more likely to survive stroke:
If you don’t die, because sometimes some people are 
strong in their body, you have stroke. (Interview M)
Another participant (a UK-born, retired man who was 
not taking treatment) used the same ‘strong’ and ‘weak’ 
terminology, perceiving that weaker people were likely 
to die from hypertension. He contrasted himself with his 
wife whom he perceived as weaker:
I think there are certain people, I keep referring 
to me, there’s certain people who are stronger and 
some are weaker. You know, my wife’s very weak, she 
would take any tablet you gave her for anything; she 
wouldn’t take two a day but she’d take one a day 
of those tablets, you know what I mean, and if they 
said she had chronic whatever she would read about 
it and say ‘Yes, yes, I’ve got this, this sounds [like] 
me. (Interview A)
Similarly, a UK-born participant (a retired health profes-
sional) described that her sister, by living an unhealthy 
lifestyle, had become susceptible to illnesses in general:
She didn’t really look after her body much. She didn’t 
do any exercise, it was all sitting down. And she’s had 
a stroke, she had a stroke before the age of 80. She’s 
now… she’s 82…she’s very sedentary, she’s surpris-
ingly upbeat for having had a stroke…she’s too over-
weight, and so on. I just feel she’s constantly having 
little infections. (Interview P)
Comparing risk with peers
Several participants talked about their risk of by 
comparing themselves to peers or family (illustrated by 
the quotation from interview P, above). One participant 
(who had training in statistics) reported his own risk in a 
similar way.
I’d say probably in the top five to ten percent of peo-
ple of my age, myself, well I’ve always played sport, 
played rugby until I sort of got too old and too 
crocked and knocked and played squash ever since… 
(Interview I)
One participant explained the fact she had not devel-
oped complications from hypertension by comparing her 
own response to the diagnosis with that of her father-in-
law’s; her own reaction included obtaining and taking 
medication, addressing being overweight through bari-
atric surgery and keeping as active as possible.
My father in law was diagnosed as having quite high 
blood pressure, and he turned himself into an in-
valid overnight practically, he did nothing, and it 
made matters worse as he died suddenly of a heart 
attack… So that’s a completely different reaction to 
mine I think. (Interview C)
DIsCussIOn
This study sought to examine experiences and ideas 
about cardiovascular risk from the perspective of people 
with hypertension. A key theme was the concept of 
patients as individuals. Notably, no one who was inter-
viewed described their own risk in terms of probability. 
Around half of the participants expressed doubt that a 
risk communication tool could apply to them personally. 
Many of these participants felt that the use of the phrase 
‘people who are similar to you’ was of dubious reliability, 
since they felt the reference group would not be suffi-
ciently similar to them. For some participants, ensuring 
that statistical estimates took adequate account of factors 
they held important would lead them to be useful. 
However, for many, no population statistic would be 
applicable to them as individuals, since no two people are 
exactly alike. Similarly, several participants did not inter-
pret the risk presentation as probabilistic, but instead 
pointed at the numerator of the fraction saying, ‘I’d be 
one of those ones’. Participants widely expressed their 
risk in terms of their peers: typically siblings or friends of 
a similar age.
Many of the participants expected that medication 
would be highly protective; several expressed surprise 
at the small size of benefit displayed on the risk chart 
example; one of whom expressed disbelief. Several 
participants expected medication would provide abso-
lute protection against complications from hypertension. 
This mirrors the results of quantitative analyses of patient 
expectations of treatment for a number of conditions; a 
systematic review found the majority of 27 323 participants 
of 35 studies overestimated the benefit and underesti-
mated harm from a wide range of medical treatments.21
Parallels may be drawn between many of the themes 
raised in this study and debate about the problems with 
risk communication raised in the academic literature.8 
The concerns expressed by participants echo the reference 
class problem.22 Given that individuals have an unlimited 
number of characteristics and can potentially belong to 
many populations, which population does the risk esti-
mate describe? Several existing decision aids do report a 
clear denominator (and making a denominator clear is a 
key recommendation in guidelines on the production of 
decision aids),17 but some do not make this distinction. 
The heart-to-heart decision aid describes cardiovascular 
risk using the following form of words:
your risk of having a cardiovascular event in the next 
10 years is 11%.23
One difference in our study is that the example risk 
description did have a clearly stated reference population 
(stated as ‘Imagine 100 people who are similar to you 
(same sex, same blood pressure, cholesterol, and smoking 
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status’). Here, all but one of the participants seemed to 
understand the reference category, but most perceived it 
to be irrelevant. Many participants expressed that their 
personal characteristics could not be adequately incorpo-
rated into a statistical estimate.
For many of the participants, risk estimates could not 
sufficiently take account of the particular risk factors 
that they perceived to be most important. Emmons 
and colleagues reported similar findings in their focus 
group study, which examined patient perspectives on the 
Harvard Cancer Risk Index (a tool that presents a person-
alised estimate of cancer risk to patients based on their 
weight, smoking, alcohol consumption, family history 
and history of inflammatory bowel disease).24 They found 
many participants held certain factors as important that 
were not incorporated by the tool (including poverty, air 
pollution and exposure to toxic waste). The absence of 
these factors caused these participants to view the final 
risk score with some scepticism. The qualitative study by 
Damman et al found that participants reported similar 
risk factors for CVD as experts but that they assigned 
them different values: an unhealthy lifestyle (and partic-
ularly high levels of stress) was seen as the predominant 
cause by the lay participants, whereas experts gave similar 
weighting to advancing age and genetics.13 Bonner et 
al in their ‘talk-aloud’ study found that CVD tools that 
accounted for a greater number of risk factors were seen 
as more credible.14 Our study suggests that the number 
of risk factors might be less important than whether the 
risk factors used match those that patients perceive as 
important.
However, the choice and weighting of variables in CVD 
risk algorithms is guided more by statistical and prag-
matic concerns. For example, QRISK selected risk factor 
variables that are routinely collected in electronic health 
records. This allowed the use of a vast dataset (health 
records from 11 million patients) to derive model param-
eters25 and also allows clinicians to calculate risk estimates 
in the consultation using data that often already exists 
on the patient record and without the need for onerous 
collection of additional data.
The trade-off of this approach is that the model is highly 
dependent on the variables that happen to have been 
collected. In UK primary care records, blood pressure, 
cholesterol levels and smoking status are readily available 
with good data completeness. Diet and physical activity, 
although both recognised as important risk factors, are 
not routinely collected in a standardised way (and are 
intrinsically more complex to quantify). The participants’ 
concerns that risk estimates did not take into account 
their lifestyle changes are therefore valid.
Of the participants of this study who did express an 
idea of their own risk, all used comparisons with peers 
and family members. This used spontaneously by most 
of the participants and including a number of those who 
wished to avoid consideration of risk in a probabilistic 
sense. Interestingly, this method also overcomes the refer-
ence class problem. By comparing themselves to peers 
(typically friends and siblings close in age), participants 
were able to have an understanding of their risk as an 
individual.
Although most current CVD risk tools generate an indi-
vidualised percentage risk, the Dundee Heart disease rank 
(one of the earliest methods for calculating a global CVD 
risk) does evaluate an individual’s risk in comparison with 
their peers. Using this approach, individuals are assigned 
a position in a ‘coronary queue’ of 100 people.26 The 
‘queue’ is designed to represent the general population 
of the same age (or age group) as the target individual. 
The queue position was determined by reference to the 
risk factors of 10 359 men and women aged 40–59 years 
in the Scottish Heart Health Study. This reference group, 
like the peers and family members described here, were 
not differentiated by risk. Current standard risk estimate 
percentages (eg, as those generated by QRISK2 or the 
Framingham score) could be translated to a population 
rank, given knowledge of the risk estimates of a sample 
of the general population in a particular age group. Risk 
calculation tools are widely used, and therefore popu-
lation data should be easy to collect, for example, from 
analysis of routine primary care records data. We provide 
an illustrative example of how such an approach might 
work in figure 3. One disadvantage is that this approach 
still ultimately relies on conventional risk models (which 
still often do not include the variables participants hold 
to be most important). Nonetheless, such a presentation 
could overcome some of the comprehension issues iden-
tified in this study and is worthy of further investigation. 
Most empirical studies of CVD risk formats have focused 
on presenting population absolute risks,27 and though a 
small number of studies have examined the provision of a 
population reference risk as a comprehension aid,28 none 
(to our knowledge) have assessed how patients respond 
to a rank system.
strengths and limitations of the study
We were largely successful at recruiting people of a wide 
range of geographic, ethnic and socioeconomic back-
grounds and with a wide range of durations since diag-
nosis and recruiting both men and women. People of a 
wide range of ages were recruited; participants ranged 
from 51 years to 90 years, corresponding roughly with 
the age-specific disease burden found in population 
studies. However, we were unable to recruit anyone 
younger than aged 50 years, despite offering the oppor-
tunity for evening or weekend interviews (the expected 
prevalence of hypertension for those aged 40–49 years 
is around 20%, although most this group will be either 
unaware or aware but untreated).29 This group may 
have different attitudes towards risk and information 
than the older age groups. Key themes (including not 
wishing to contemplate future risk) did occur in inter-
views were not limited to older participants and also 
arose in interviews with participants in the younger part 
of the range. Similarly, there was no obvious impact 
of ethnicity or country of origin (although overall 
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numbers were small to determine such a link): the key 
themes were repeated in participants of a variety of 
backgrounds.
The dual role of a clinician as a researcher may affect 
participant responses and make it difficult to remain 
impartial.30 In this study, there is a risk that participants 
who were aware that the interviewer was a general prac-
titioner would be less likely to talk openly about medi-
cation non-adherence and be reticent to reveal views 
they perceive the interviewer would disapprove of. Simi-
larly, as a requirement of the ethics process, the initial 
approach had to be from the participant’s own clinical 
team. We aimed to avoid the appearances of a clinical 
consultation as much as possible (the interviewer intro-
duced himself as a PhD student, dressed casually and the 
interview room was not set up as a consulting room). We 
additionally made clear both on written information, and 
verbally at the beginning of interviews, that all informa-
tion remained confidential and would not be shared with 
their doctor. It is possible, nonetheless, that participants 
were reluctant to talk openly about decisions to avoid 
prescription medication.
It is possible that our example decision aid (which 
was designed similarly to many others used in practice) 
influenced participants responses. To limit this as much 
as possible, we showed participants the aid as the final 
part of the interview. Additionally, many of the partici-
pants responded to the information in the aid in unex-
pected ways (eg, identifying themselves with the affected 
portion of the risk fraction, rather than interpreting as a 
probability).
COnClusIOns
Risk communication requires the successful transmis-
sion of a statistical probability and the the communi-
cation of the context and meaning of the number. For 
those who want to engage in discussions about risk, 
tools that incorporate risk factors that are important 
to patients may be perceived as more meaningful. 
However, for many, risk in the format commonly used 
in current decision aids and predictive tools (ie, explic-
itly or implicitly presenting the risk of ‘100 people like 
you’) was not seen as relevant, since they did not iden-
tify with the denominator. Some did not believe that 
any reference group could be sufficiently like them 
and sought risk information that would apply to them 
as an individual. Ranking an individual’s risk against 
their peers may be more acceptable and relevant than 
conventional probabilistic approaches.
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